The biological basis of antipsychotic response in schizophrenia

Research output: Contribution to journalLiterature reviewpeer-review

42 Citations (Scopus)


Schizophrenia is a severe mental illness affecting approximately 1% of the population worldwide. Antipsychotic drugs are effective in symptom control in up to two-thirds of patients, but in at least one-third of patients the response is poor. The reason for this is not clear, but one possibility is that good and poor responders have different neurochemical pathologies, and may therefore benefit from different treatment approaches. In this selective review we summarise research findings investigating the biological differences between patients with schizophrenia who show a good or a poor response to treatment with antipsychotic drugs.
Original languageEnglish
Pages (from-to)953-964
Number of pages12
JournalJournal of Psychopharmacology
Issue number7
Publication statusPublished - Jul 2010


Dive into the research topics of 'The biological basis of antipsychotic response in schizophrenia'. Together they form a unique fingerprint.

Cite this